Pajzsmirigyrák: vizsgálatok itt: Kanada
8 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in KanadaA Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies
- Where
- Vancouver
- Életkor
- 18 év and over
- People
- 60
- Run by
- British Columbia Cancer Agency
See details and how to joinNCT07621146 - 1. fázisTaking peoplePhase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
- Where
- Montreal
- Életkor
- 18 év to 100 év
- People
- 116 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07006727 · EU 2024-519111-34-00 - 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Montreal, Toronto
- Életkor
- 8 év and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00 - 1/2. fázisTaking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Edmonton, Ontario, Ottawa, Toronto, Vancouver
- Életkor
- 12 év and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - No phaseTaking peopleRadiofrequency Ablation for Curative Treatment of Small Low-Risk Papillary Thyroid Cancer: Pilot Study
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 30
- Run by
- University Health Network, Toronto
See details and how to joinNCT07376837 - No phaseTaking peopleConcordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples
- Where
- Calgary
- Életkor
- 18 év and over
- People
- 130
- Run by
- University of Calgary
See details and how to joinNCT06133374 - 2. fázisTaking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Edmonton, Montreal, Toronto, Winnipeg
- Életkor
- 18 év and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00 - No phaseTaking peopleThe Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer
- Where
- Toronto
- Életkor
- 18 év to 100 év
- People
- 40
- Run by
- University Health Network, Toronto
See details and how to joinNCT06929650